|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Nitric oxide (NO) upregulates ciliary beat frequency (CBF). The present study evaluates mechanisms of the NO-cyclic guanosine monophosphate (cGMP) pathway regulation of CBF. Rat tracheal explants were loaded with 4,5-diaminofluorescein diacetate for the demonstration of NO production by ciliated epithelial cells after L-arginine (L-Arg) stimulation. CBF was measured using phase contrast microscopy and videotape analysis. The roles of NO, soluble guanylate cyclase (sGC), cGMP-dependent protein kinase (PK) G, and phosphodiesterase (PDE) V in regulation of CBF were evaluated. NO synthase (NOS) was activated with L-Arg or inhibited with NG-monomethyl-L-Arg. sGC was stimulated with NO donors 1-hydroxy-2-oxo-3- (N-ethyl-2-aminoethyl)-3-ethyl-1-triazene and S-nitroso-L-glutathione or mimicked by 8-bromo-guanosine 3',5'-cyclic monophosphate (8-Br-cGMP) and inhibited with 1H-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one. The effects of the PKG inhibition with KT5823 and PDE V inhibition with Zaprinast were also examined. The studies demonstrate that ciliated epithelial cells produce NO, which is correlated with CBF stimulation. L-Arg dose- and time-dependently increases CBF, and NO donors, 8-Br-cGMP, and Zaprinast also enhance CBF. Inhibitors of NOS, sGC, and PKG can block the stimulant effect of L-Arg on CBF. Thus, NO is a regulator of CBF acting via sGC and PKG. The NO-cGMP signaling pathway regulates CBF in an autocrine manner in cultured rat ciliated airway epithelium.
| |
Introduction |
|---|
|
|
|---|
Normal airway mucociliary clearance plays an important role in the host defense mechanism that clears the upper airways of inhaled particles, such as dusts, aerosols, bacteria, and air pollutants (1). This defense mechanism is dependent upon the production of mucus and the coordinated beating of ciliated cells that line the surface of the airway lumen. Cilia in the airway continually beat at a baseline frequency to sweep debris toward the glottis under normal physiologic conditions (2). In disease states, such as airway inflammation or infection, the mucociliary clearance function is altered either by increased mucus production or by damaged ciliary beat frequency (CBF) (1, 3).
Nitric oxide (NO) is an important cell-signaling molecule that affects many critical cell functions (4). NO is
present in the exhaled air of humans, and low levels of nasal NO correlate with impaired mucociliary function in the
upper airways (5). Moreover, there is no NO production in
patients with Kartagener's syndrome (6, 7). There is increasing evidence that the NO-cyclic guanosine monophosphate (cGMP) signaling pathway plays an important role
in CBF regulation. NO is released by an enzyme family of NO synthases (NOSs) from the substrate L-arginine (L-Arg).
There are at least three known isoforms of NOS and all
of them
the neuronal, inducible, and endothelial NOS
(eNOS)
have been found in airway epithelial cells (8).
Further, release of NO in rabbit tracheal mucosa (11) and
synthesis of cGMP in human airway epithelium (12) have
been reported previously. In addition, inhibition of NOS
has been shown to attenuate CBF stimulation induced by
-adrenergic stimulants (11), cytokines (13, 14), and methacholine (15, 16). Direct application of 8-bromo-guanosine
3',5'-cyclic monophosphate (8-Br-cGMP) enhances CBF
in cultured human nasal airway epithelial cells (12).
Most of the biologic functions of NO are mediated through its receptor protein, soluble guanylate cyclase (sGC), which catalyzes guanosine triphosphate into cGMP. cGMP activates protein kinase (PK) G, which may participate in the regulation of CBF. Moreover, a recent study from our laboratory demonstrated that eNOS, sGC, and PKG I are colocalized in rat airway ciliated epithelial cells, implicating the involvement of the NO-cGMP signaling pathway in the regulation of CBF (17). Previous studies have suggested that CBF is regulated by the parasympathetic nervous system (15), NO (5, 13, 14), and PKA and PKG (16, 18). Recently, a new fluorescent indicator for NO, diaminofluorescein (DAF), has been developed by Kojima and colleagues (19, 20). DAF has been shown to visualize intracellular NO with high sensitivity (detection limit, 5 nM) and specificity in cultured vascular smooth-muscle cells. For verifying the NO production by ciliated cells, we stained the ciliated cells with DAF-diacetate (2DA), a cell-permeable NO indicator of DAF. We demonstrated for the first time that ciliated cells produce NO, and we also explored the regulatory effects of different components of the NO-cGMP signaling pathway on CBF in cultured rat airway ciliated cells. The results indicate that ciliated airway epithelial cells actively produce NO and that NO regulates CBF in the rat airway ciliated epithelial cells.
| |
Materials and Methods |
|---|
|
|
|---|
Reagents
Dulbecco's modified Eagle's medium (DMEM) and antibiotics were from GIBCO BRL (Grand Island, NY). Fetal bovine serum (FBS) was from Hyclone (Logan, UT). 4,5-DAF-2DA was from Calbiochem (La Jolla, CA). S-nitroso-L-glutathione (GSNO), 1-hydroxy-2-oxo-3-(N-ethyl-2-aminoethyl)-3-ethyl-1-triazene (NOC 12), NG-monomethyl-L-arginine (L-NMMA), 1H-[1,2,4]oxadiazole [4,3-a]quinoxalin-1-one (ODQ), KT5823, 8-Br-cGMP, and Zaprinast were from Alexis Corp. (San Diego, CA). L-Arg, D-arginine (D-Arg), dimethyl sulfoxide (DMSO), and all other chemicals were obtained from Sigma (St. Louis, MO).
DAF-2DA, ODQ, and KT5823 were dissolved in DMSO/H2O (1:1) first and diluted further in phosphate-buffered saline (PBS), pH 7.5. All the other mediators used were dissolved in PBS and were freshly prepared before each experiment. The final concentration of DMSO was not more than 0.1%.
Preparation and Culture of Rat Tracheal Epithelial Cells
The rat tracheal epithelial explant culture followed the methods described by Dirksen and associates (21) with minor modifications. Briefly, adult Sprague-Dawley rats (300 to 350 g body weight; Hilltop, Scottdale, PA) were anesthetized with isoflurane (Ohmeda PPD, Liberty Corner, NJ) and the chests were opened, then the heart, lung, and trachea were quickly removed. The tracheas were cut into 0.5- to 1-mm3 pieces of tissue explants, which were placed on coverslips precoated with rat-tail collagen. The explants were incubated in DMEM containing 10% FBS, 25 mM N-2-hydroxyethylpiperazine-N'-ethane sulfonic acid, and 0.37% NaHCO3 at 37°C, 5% CO2. After 3 to 6 d of culture, the single-layered ciliated cells appeared at the edge of the explants. Clusters of three to six ciliated cells within a ×40 objective field were selected for CBF measurement. Only explants free of any bacterial or fungal contamination were used for the experiments.
Measurement of NO Production and CBF
For measuring NO production, coverslips with cultured rat airway ciliated epithelial cells were washed with Krebs-Ringer phosphate (KRB) buffer (120 mM NaCl, 4.8 mM KCl, 0.54 mM CaCl2, 1.2 mM MgSO4, 11 mM glucose, and 15.9 mM sodium phosphate, pH 7.2). Then the cells were incubated at 37°C in 10 µM DAF-2DA in KRP buffer for 1 h and mounted under an inverted phase contrast Olympus IMT-2 fluorescence microscope (Olympus, Tokyo, Japan) fitted with a cube containing a 495-nm excitation filter, 515-nm emission filter, and 505-nm dichroic mirror. The microscope was linked to a Toshiba 3CCD camera (Toshiba, Tokyo, Japan) and I-Cube computer image analysis system (I-Cube, Cambridge, MA). A ×40 objective was used to obtain the image of the cells. For observation of the fluorescence of NO produced by the ciliated cells, 10 mM L-Arg was added to the KRP buffer, the fluorescence was observed with ultraviolet (UV) light, and the image was captured with the video camera at 0 and at 25 min after adding L-Arg. To avoid damage to the ciliated cells, the exposure to UV light was only for 2 to 4 s. Only the intensity of the fluorescence of the ciliated cells in the selected fields was measured with Image-Pro software (Media Cybernetics, Silver Spring, MD), then compared with the 0 time-point results.
For the analysis of CBF in the ciliated cells, the baseline CBF was recorded with a JVC VCR HR-S5400U tape recorder (JVC, Tokyo, Japan) for 5 min, then L-Arg was added and recording continued for an additional 25 min with phase contrast illumination only. The videorecorded CBF was analyzed frame by frame using Adobe Premiere software (Adobe Systems, Inc., San Jose, CA). The analyzers were blinded during the CBF measurements. NO production (fluorescence intensity) and the CBF were correlated later.
Measurement of CBF Only
For the analysis of CBF in rat airway ciliated epithelial cells, tracheal explants were cultured on coverslips for 3 to 6 d in DMEM plus 10% FBS. Before experimentation, the coverslips were marked on the edges with a Dako pen (Dako, Carpinteria, CA) to avoid leaking of medium and then 500 µl of DMEM with 0.037% NaHCO3 was added on the top. The coverslips were mounted under an inverted phase contrast Olympus microscope and the image was observed and videotaped as described earlier. Actively beating ciliated cells were selected from the field with at least three ciliated cells close to each other. All the experiments were carried out at a constant temperature of 24 ± 1°C, and at pH 7.4 to 7.6. The experiments were repeated three to 12 times (expressed as n number) according to different mediators tested. NO elevating agents and stimulants or inhibitors of the NO-cGMP signal transduction pathway were applied to examine their effects on ciliary frequency. NO donors such as L-Arg or NOC 12 (0.1 mM), and GSNO (0.1 mM), were applied. A dose-related range of different concentrations of L-Arg (at final concentrations of 0.01, 0.1, 1, and 10 mM) was added into the 500 µl of medium on top of the coverslips. Both 8-Br-cGMP (1 mM) and Zaprinast, a cGMP-specific phosphodiesterase (PDE) V inhibitor (0.1 mM), were tested for their CBF stimulating effects.
The effects of different inhibitors of the NO-cGMP signal transduction pathway, including the NOS inhibitor L-NMMA (1 mM), sGC inhibitor ODQ (from 0.1 to 100 µM), and PKG inhibitor KT5823 (0.03 to 30 µM), on L-Arg-stimulated CBF enhancement were examined. D-Arg (0.1 mM) and NG-monomethyl-D-arginine (D-NMMA) (10 mM), the dextrorotatory enantiomers of L-Arg and L-NMMA, were also used as controls.
Statistical Analysis
All data are expressed as the mean ± standard error of mean. For
the correlation of NO production and CBF stimulation, simple regression analysis was used. For the time-course response, the CBF was expressed as Hz (beats/s) and the comparisons were
carried out between baseline and different time points using two-factor repeated-measures analysis of variance (ANOVA). For
the dose-dependent response, the percentage change (baseline = 100%) in CBF was used as the measurement of the response of
CBF to stimulus by the various mediators. This was done to permit the comparison of preparations with differing initial CBF.
The comparisons were taken between
5 and 0 min (baseline)
and 25 min after adding the mediators for the dose-dependent response of various mediators, and the time-matched data were
compared using one-way ANOVA after the Bonferroni test. A
value of P < 0.05 was considered statistically significant.
| |
Results |
|---|
|
|
|---|
NO Production by Ciliated Epithelial Cells and Its Correlation with CBF Enhancement
For the demonstration of NO production by the cultured ciliated epithelial cells, DAF-2DA (10 µM) was added to the cells, then 10 mM L-Arg was applied. The ciliated cells of the rat airway produced NO and became fluorescent (Figure 1, arrows). The other cells without cilia in the same culture only showed very low levels of NO production. To further elicit the effects of NO produced by ciliated cells, CBF was measured and only the changes in intensity of fluorescence in the ciliated cells were quantified and compared before and after L-Arg stimulation. These experiments demonstrate that 10 mM L-Arg (n = 6) increased CBF 28% compared with basal (n = 7, vehicle only) CBF at the 25-min time point (P < 0.0001, one-way ANOVA, Bonferroni test). At the same time, NO production, as measured by its fluorescent intensity in the ciliated cells, increased 30% (P = 0.0041, one-way ANOVA, Bonferroni test) (Figure 2). Comparison by correlation of the increase of CBF with NO production resulted in the highly significant r value of 0.76 (P = 0.0026), as shown in Figure 3. The NOS inhibitor L-NMMA (10 mM) inhibited L-Arg- induced NO production (DAF fluorescent intensity) and attenuated CBF significantly compared with D-NMMA (P < 0.0001; Figure 4). In contrast, D-Arg and D-NMMA had no effects on CBF and DAF fluorescent intensity.
|
|
|
|
Effects of NO Donors Such as L-Arg, NOC 12, and GSNO on CBF
To determine the effects of NO on CBF, different NO donors and stimulators were used. L-Arg at 1 mM induced a significant (20%) increase of CBF compared with baseline CBF. Moreover, the L-Arg increase in CBF was time-dependent; an increase of CBF over baseline was detectable by 5 min and reached a peak at 25 min after L-Arg stimulation (P < 0.05). Further, to determine whether the increase of CBF in response to L-Arg was dose-dependent, 0.01 (n = 4), 0.1 (n = 6), 1 (n = 7), and 10 mM (n = 3) of L-Arg were used. At the concentrations of 0.01 and 0.1 mM, L-Arg caused a slight (from 5 to 10%) increase but no significant effect on CBF stimulation. With the increase of the concentration to 1 and 10 mM of L-Arg, the CBF increased considerably from 15 to 20% (P < 0.05 compared with baseline CBF; Figure 5). To determine whether the increase in CBF seen with L-Arg is NOS-specific, the ciliated cells of the explants were exposed to equimolar (1 mM) concentrations of D-Arg. The results, as expected, demonstrated that D-Arg (n = 6) had no effect on CBF stimulation (Figure 5). Similar stimulating effects of NO were also seen with different NO donors, such as NOC 12 (0.1 mM, n = 7) and GSNO (0.1 mM, n = 5). All the NO donors increased CBF significantly and in a time-dependent manner (Figure 6).
|
|
Effects of cGMP Elevating Agents on CBF
To determine whether the CBF-stimulating actions of the NO-cGMP signal transduction pathway were mediated through cGMP, different concentrations of 8-Br-cGMP (10 µM, n = 4; 100 µM, n = 5; and 1,000 µM, n = 12) were applied to the cultured epithelial cells. 8-Br-cGMP increased CBF in a time- and concentration-dependent manner with a significant (10%) increase over control occurring at 100 µM (Figure 7). The increase of CBF was detectable at 5 min and lasted until 25 min after 8-Br-cGMP administration. In addition, Zaprinast, a cGMP-specific PDE V inhibitor, showed the same effect. At 0.1 mM concentration, Zaprinast increased CBF 30% from 7.8 ± 0.5 to 9.3 ± 0.3 Hz. The increase became detectable at 5 min and peaked at 20 min after Zaprinast addition (Figure 8).
|
|
Effects of Different Inhibitors of the NO-cGMP Signaling Pathway on CBF
To determine whether the L-Arg-induced increase of CBF was dependent upon the NO produced by NOS from ciliated cells, the cells were exposed to media containing 1 mM L-Arg followed by 0.1 to 10 mM L-NMMA, a stereospecific NOS inhibitor, or 10 mM D-NMMA, the inactive enantiomer of L-NMMA. L-NMMA had no effect on baseline CBF, but dose-dependently inhibited the CBF stimulated by 1 mM L-Arg (Figure 9). Pretreatment of ciliated cells with L-NMMA prevented L-Arg-induced increase of CBF (data not shown). D-Arg did not enhance CBF and D-NMMA had no effect on L-Arg-stimulated CBF.
|
To determine whether the L-Arg-induced increase in CBF was mediated by sGC and PKG, ODQ (a specific inhibitor of sGC) and KT5823 (a specific PKG inhibitor) were added. In addition, the inhibitory effects of ODQ (inhibition constant [Ki] = 3 µM) on the L-Arg-induced increase in CBF occurred in a dose-dependent manner. At 0.1 µM (n = 4), ODQ had no inhibitory effects at all; at 1 µM (n = 4) it inhibited L-Arg-induced CBF by 8 ± 2.2%; at 10 µM (n = 4), by 15 ± 1.8%; and at 100 µM (n = 5), complete inhibition was achieved (Figure 10).
|
KT5823 (Ki = 0.2 µM) showed similar dose-dependent inhibitory effects on L-Arg-induced increase of CBF: at 0.03 µM (n = 4) KT5823 exhibited no inhibition, but at 0.3 µM (n = 5) it reached 15 ± 1.9% inhibition. At 3 (n = 4) and 30 µM (n = 6), KT5823 completely inhibited L-Arg- induced increase of CBF (Figure 11).
|
| |
Discussion |
|---|
|
|
|---|
The current studies provide a physiologic correlation to an
initial observation (using immunoelectron microscopy for
eNOS) that the eNOS protein is specifically localized to
the basal microtubule membrane in ciliated epithelium of
rat lung (10). Other studies have indirectly suggested a
role for NO in regulating ciliary motility (5, 8, 10). Recently,
a novel NO indicator, DAF, was described which has high
specificity and sensitivity in detecting NO produced by living cells (19, 20). DAF was first used for measurement of
NO production in cultured rat aortic smooth-muscle cells
after activation with interleukin-1
, tumor necrosis factor-
, and lipopolysaccharide. Then the cells were treated
with DAF-2DA, a cell-permeable and nonfluorescent derivative of DAF. In the cells DAF-2DA is converted by intracellular esterase to DAF-2, which is nonfluorescent and
remains in the cells. NO produced by the cells rapidly converts DAF-2 to highly fluorescent triazolofluorescein (DAF-2 T). The NO production and DAF fluorescence
were observed and the fluorescence intensity in the activated
smooth-muscle cells increased with time owing to DAF-2
T production from DAF-2 by reaction with NO. The intensity was suppressed by the NOS inhibitor L-NMMA.
The DAF fluorescent staining is specific and sensitive (5 nM). Stable oxidized forms of NO, such as NO2
and
NO3
, and other reactive oxygen species, such as O2
,
H2O2, and ONOO
, do not react with DAF-2 to yield any
fluorescent product. Under physiologic conditions, DAF-2
T is not formed in the absence of NO (19, 20).
In this study, using this new NO indicator, we indirectly demonstrated NO production in cultured rat airway ciliated epithelial cells. Further, we also showed that the increased NO levels are correlated with the enhancement of CBF induced by L-Arg. Activation of NOS and PKG enhanced this response, and inhibition of NOS, sGC, and PKG inhibited it. We conclude that NO produced by rat airway ciliated epithelial cell may act as a modulator to stimulate CBF in an autocrine/paracrine manner.
A variety of stimulants can increase CBF. Previous reports have shown that ethanol (22), bradykinin (11, 23), Zaprinast (24), cytokines (14), methacholine (15), prostacyclin (25), and isoprenaline (26) can stimulate CBF. NOS inhibition has been shown to inhibit ethanol-elicited increase of CBF (27). A recent study reported by Venkov and coworkers (27) demonstrated that ethanol can stimulate eNOS protein and messenger RNA expression in cultured bovine endothelial cells. Whether this accounted for the NO-dependent ethanol response in airway epithelial cells is unknown. Also, L-Arg and other NO donors, such as sodium natroprusside, have been shown to reverse the effects of NOS inhibition on ethanol-induced enhancement of ciliary motility (22). In the present study we demonstrated that L-Arg-induced CBF activity in a dose- and time-dependent manner (see Figure 5), and that inhibition of NOS reduced NO production (DAF staining intensity) and attenuated CBF. In addition, an increase of intracellular cGMP levels, either by adding 8-Br-cGMP or by inhibiting cGMP-specific PDE using Zaprinast, resulted in effects identical to those from addition of NO to the ciliated epithelial cells (see Figures 7 and 8). In contrast, D-Arg did not show any cilia-stimulating effects, and inhibition of NOS activity with L-NMMA but not D-NMMA, inhibition of sGC activity with ODQ, or inhibition of PKG activity with KT5823 attenuated the cilio-stimulating effects of L-Arg (see Figures 9-11). These results are in agreement with previous suggestions (11, 12, 15, 16, 18) that the NO-cGMP signaling pathway regulates CBF.
The controversial effects of cGMP and cGMP-elevating agents, such as C-type natriuretic peptide (CNP) and atrial natriuretic factor (ANF), on CBF are very difficult to explain, as CNP stimulates and ANF inhibits CBF (28, 29). In the present study we demonstrated that 8-Br-cGMP stimulates CBF in a time- and dose-dependent manner (see Figure 7). This result is in agreement with a previous report by Geary and colleagues (12) which demonstrated that direct application of 8-Br-cGMP enhanced CBF in cultured nasal airway epithelial cells. A recent study by Uzlaner and Priel (30), in contrast, showed that use of 100 µM dibutyryl-cGMP (db-cGMP), another analogue of cGMP, failed to increase CBF in cultured rabbit tracheal epithelial cells. At the same time, db-cGMP did not change the plateau of intracellular calcium. Uzlaner and Priel suggested that the failure of db-cGMP to induce Ca2+ influx and to stimulate CBF might indicate that an additional factor other than activated PKG is at work (30).
The regulation and control of CBF in the airways is a very complicated process and many pathways have been implicated to play a role in the modulation of CBF (2). Several PKs have been implicated. Activation of PKG or PKA will result in an increase of CBF (16, 18, 30). PKC actions have been controversial. Levin and colleagues (31) demonstrated that activation of PKC induced calcium influx and sustained enhancement of CBF by extracellular adenosine triphosphate (ATP) in frog esophagus epithelium; in contrast, Uzlaner and Priel (30) reported inhibitory effects of PKC on CBF enhancement in rabbit tracheal ciliated epithelial cells. An explanation for this discrepancy may be based upon the species differences, but other unknown factors cannot be excluded. Several reports have demonstrated a dual regulation of CBF by PKA and PKG (16, 18). This may not be simply explained by phosphorylation or dephosphorylation of the components involved in the ciliary motility. Although our results clearly show that CBF enhancement by L-Arg can be attenuated by sGC or PKG inhibition with ODQ or KT5823, respectively, the exact mechanism(s) of how the NO-cGMP signal transduction pathway regulates CBF is still unknown. Particularly, the inhibitors used in our experiments, such as PKG inhibitor KT5823 (Ki = 0.2 µM), attenuated L-Arg- induced CBF at 0.3 µM and completely inhibited L-Arg- induced increase of CBF at 3- and 30-µM concentrations (see Figure 11), but also inhibited bromo-cyclic adenosine monophosphate (Br-cAMP)-induced increase of CBF (data not shown) in our system. The lack of relative specificity of this inhibitor and the cross-talks between PKA and PKG signaling pathways in the regulation of CBF need to be further elucidated.
Previous reports found that CBF may be regulated by
modulating the intracellular Ca2+ concentration ([Ca2+]i).
Korngreen and Priel (32, 33) found that extracellular ATP
induced a rapid and strong (4- to 5-fold) increase in
[Ca2+]i in the rabbit airway epithelia. This effect was transient, decaying after 3 to 4 min, whereas CBF enhancement induced by extracellular ATP was rapid and prolonged, continuing for 20 to 30 min. Using a technique that
allows simultaneous measurement of [Ca2+]i and CBF,
these investigators revealed that [Ca2+]i decayed to a sustained, higher-than-basal plateau. Manipulations that lowered this sustained plateau of [Ca2+]i caused the CBF to
decay rapidly to its basal value. Most recently, using the
same system, Uzlaner and Priel reported that there is an
interplay between the NO-cGMP signal transduction
pathway and elevated [Ca2+]i that enhances ciliary activity
in rabbit trachea (30). They found that PKC is not involved in the regulation of CBF and [Ca2+]i. KT5823 and
LY-83583, an sGC inhibitor, and N
-nitro-L-arginine methylester, a NOS inhibitor, did not change the peak of [Ca2+]i
but altered the plateau of [Ca2+]i; meanwhile, ATP-induced CBF enhancement was significantly attenuated. They concluded that the elevated [Ca2+]i is a strong stimulator of NOS, which activated sGC and PKG via the NO-cGMP signal transduction pathway. The activation of PKG
plays a crucial role by inducing the elevated [Ca2+]i levels
required for sustained activation of NOS and CBF enhancement (positive feedback). Unfortunately, these data still do
not provide a detailed mechanism of how the NO-cGMP signal transduction pathway regulates CBF.
Both cAMP and cGMP increase the swimming velocity of permeable cells of paramecium reactivated with ATP and also increase dynein-like adenosine triphosphatase activity in permeable cells of paramecium and in motile cilia preparations (34). Studies reported that phosphorylation of ciliary dyneins by PKs from paramecium (34), from Chlamydomonas flagella (35), and from Ciona sperm plays an important role in regulating their motility. Whether the NO-cGMP signal transduction pathway stimulates CBF by phosphorylating these ciliary motor components, and whether this is related to the elevation of [Ca2+]i in rat airway ciliated cells, need further study.
In summary, in this study we demonstrated that NO production by cultured airway ciliated epithelial cells and the increased NO correlated with CBF stimulation. Increases in NO or cGMP stimulate CBF, and inhibition of the activity of the NO-cGMP signaling pathway attenuates L-Arg-induced CBF stimulation. The limitation of this study is that there is a mixed cell population in the culture system; other cells such as fibroblasts, endothelial cells and smooth-muscle cells may produce NO, which may affect CBF. Using single ciliated cells or cultured pure ciliated cells may eliminate the interference of CBF by the other cell types. In addition, measuring CBF in vivo under different conditions of the NO-cGMP stimulation/inhibition would provide valuable information to answer how and why NO produced by ciliated epithelial cells regulates CBF.
| |
Footnotes |
|---|
Abbreviations: analysis of variance, ANOVA; adenosine triphosphate, ATP; 8-bromo-guanosine 3',5'-cyclic monophosphate, 8-Br-cGMP; intracellular CA2+ concentration, [Ca2+]i; ciliary beat frequency, CBF; cyclic guanosine monophosphate, cGMP; diacetate, 2DA; diaminofluorescein, DAF; triazolofluorescein, DAF-2 T; D-arginine, D-Arg; Dulbecco's modified Eagle's medium, DMEM; NG-monomethyl-D-arginine, D-NMMA; endothelial NOS, eNOS; fetal bovine serum, FBS; S-nitroso-L-glutathione, GSNO; L-arginine, L-Arg; NG-monomethyl-L-arginine, L-NMMA; nitric oxide, NO; 1-hydroxy-2-oxo-3-(N-ethyl-2-aminoethyl)-3-ethyl-1-triazene, NOC 12; NO synthase, NOS; 1H-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one, ODQ; phosphodiesterase, PDE; protein kinase, PK; soluble guanylate cyclase, sGC.
(Received in original form November 12, 1999 and in revised form March 16, 2000).
Acknowledgments: This work was supported by NIH grants R01-HL 39706 and R01-GM 49111.
| |
References |
|---|
|
|
|---|
1. Wanner, A., M. Slathe, and T. G. O'Riordan. 1996. Mucociliary clearance in the airways. Am. J. Respir. Crit. Care Med. 154: 1868-1902 [Medline].
2. Yeates, D. B., G. J. Besseris, and L. B. Wong. 1997. Physicochemical properties of mucus and its propulsion. In The Lung: Scientific Foundations. R. G. Crystal and J. B. West, editors. Lippincott-Raven, Philadelphia. 487-503.
3. Braverman, I., E. D. Wright, C. G. Wang, D. Eidelman, and S. Frenkiel. 1998. Human nasal ciliary-beat frequency in normal and chronic sinusitis subjects. J. Otolaryngol. 27: 145-152 [Medline].
4. Murad, F., U. Forstermann, M. Nakane, J. Pollock, D. R. Tracey, T. Matsumoto, and W. Buechler. 1993. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication. Adv. Second Messenger Phosphoprotein Res. 28: 101-109 [Medline].
5. Lindberg, S., A. Cervin, and T. Runer. 1997. Low levels of nasal nitric oxide (NO) correlate to impaired mucociliary function in the upper airways. Acta. Otolaryngol. 117: 728-734 [Medline].
6. Lundberg, J. O., E. Weitzberg, S. L. Nordvall, R. Kuylenstierna, J. M. Lundberg, and K. Alving. 1994. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur. Respir. J. 7: 1501-1504 [Abstract].
7. Bush, A., P. Cole, M. Hariri, I. Mackay, G. Phillips, C. O'Callaphan, R. Wilson, and J. O. Warner. 1998. Primary ciliary dyskinesia: diagnosis and standards of care. Eur. Respir. J. 12: 982-988 [Abstract].
8. Xue, C., S. J. Botkin, and R. A. Johns. 1996. Localization of endothelial NOS at the basal microtubule membrane in ciliated epithelium of rat lung. J. Histochem. Cytochem. 44: 463-471 [Abstract].
9.
Xue, C.,
P. R. Reynolds, and
R. A. Johns.
1996.
Developmental expression
of NOS isoforms in fetal rat lung: implications for transitional circulation
and pulmonary angiogenesis.
Am. J. Physiol.
270:
L88-L100
10.
Asano, K.,
C. B. E. Chee,
B. Gaston,
C. M. Lilly,
C. Gerard,
J. M. Drazen, and
J. S. Stamler.
1994.
Constitutive and inducible nitric oxide synthase
gene expression, regulation, and activity in human lung epithelial cells.
Proc. Natl. Acad. Sci. USA
91:
10089-10093
11.
Tamaoki, J.,
A. Chiyotani,
M. Kondo, and
K. Konno.
1995.
Role of NO generation in
-adrenoceptor-mediated stimulation of rabbit airway ciliary
motility.
Am. J. Physiol.
268:
C1342-C1347
12.
Geary, C. A.,
M. F. Goy, and
R. C. Boucher.
1993.
Synthesis and vectorial
export of cGMP in airway epithelium: expression of soluble and CNP-specific guanylate cyclases.
Am. J. Physiol.
265:
L598-L605
13. Jain, B., I. Rubinstein, R. A. Robbins, K. L. Leise, and J. H. Sisson. 1993. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem. Biophys. Res. Commun. 191: 83-88 [Medline].
14.
Jain, B.,
I. Rubinstein,
R. A. Robbins, and
J. H. Sisson.
1995.
TNF-alpha
and IL-1 beta upregulate nitric oxide-dependent ciliary motility in bovine
airway epithelium.
Am. J. Physiol.
268:
L911-L917
15. Yang, B., R. J. Schlosser, and T. V. McCaffrey. 1997. Signal transduction pathways in modulation of ciliary beat frequency by methacholine. Ann. Otol. Rhinol. Laryngol. 106: 230-236 [Medline].
16.
Yang, B.,
R. J. Schlosser, and
T. V. McCaffrey.
1996.
Dual signal transduction modulate ciliary beat frequency in upper airway epithelium.
Am. J. Physiol.
270:
L745-L751
17.
Zhan, X.,
D. Li, and
R. A. Johns.
1999.
Immunohistochemical evidence for
the NO-cGMP signal pathway in respiratory ciliated epithelia of rat.
J.
Histochem. Cytochem.
47:
1369-1374
18.
Wyatt, T. A.,
J. R. Spurzem,
K. May, and
J. H. Sisson.
1998.
Regulation of
ciliary beat frequency by both PKA and PKG in bovine airway epithelial
cells.
Am. J. Physiol.
275:
L827-L835
19. Kojima, H., K. Sakurai, K. Kikuchi, S. Kawahara, Y. Kirino, H. Nagoshi, Y. Hirata, and T. Nagano. 1998. Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore. Chem. Pharm. Bull. Tokyo 46: 373-375 . [Medline]
20. Kojima, H., N. Nakatsubo, K. Kikuchi, S. Kawahara, Y. Kirino, H. Nagoshi, Y. Hirata, and T. Nagano. 1998. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal. Chem. 70: 2446-2453 [Medline].
21. Dirksen, E. R., F. A. Felix, and M. J. Sanderson. 1995. Preparation of explant and organ cultures and single cells from airway epithelium. Methods Cell Biol. 47: 65-74 [Medline].
22.
Sisson, J. H..
1995.
Ethanol stimulates apparent nitric oxide-dependent ciliary
beat frequency in bovine airway epithelial cells.
Am. J. Physiol.
268:
L596-L600
23.
Wong, L. B.,
I. F. Miller, and
D. B. Yeates.
1990.
Regulatory pathways for
the stimulation of canine tracheal ciliary beat frequency by bradykinin.
J.
Physiol.
422:
421-431
24. Cervin, A., and S. Lindberg. 1998. The effect of selective phosphodiesterase inhibitors on muciliary activity in the upper and lower airway in vitro. Auris Nasus Larynx 25: 269-276 [Medline].
25. Tamaoki, J., S. Sakai, A. Chiyotani, K. Takeyama, E. Tagaya, and K. Konno. 1994. Effects of prostacyclin and beraprost on ciliary motility of rabbit airway epithelium. Pharmacology 48: 194-200 [Medline].
26. Lopez-Vidriero, M. T., M. Jacobs, and S. W. Clarke. 1985. The effect of isoprenaline on the ciliary activity of an in vitro preparation of rat trachea. Eur. J. Pharmacol. 112: 429-432 [Medline].
27. Venkov, C. D., P. R. Myers, M. A. Tanner, M. Su, and D. E. Vaughan. 1999. Ethanol increases endothelial nitric oxide production through modulation of nitric oxide synthase expression. Thromb. Haemost. 81: 638-642 [Medline].
28.
Geary, C. A.,
C. W. Davis,
A. M. Paradiso, and
R. C. Boucher.
1995.
Role
of CNP in human airways: cGMP-mediated stimulation of ciliary beat frequency.
Am. J. Physiol.
268:
L1021-L1028
29.
Tamaoki, J.,
K. Kobayashi,
N. Sakai,
T. Kanemura,
S. Horii,
S. Takeuchi,
A. Chiyotani,
I. Yamawaki, and
T. Takizawa.
1991.
Atrial natriuretic factor
inhibits ciliary motility in cultured rabbit tracheal epithelium.
Am. J. Physiol.
260:
C201-C205
30. Uzlaner, N., and Z. Priel. 1999. Interplay between the NO pathway and elevated [Ca2+]i enhances ciliary activity in rabbit trachea. J. Physiol. 516: 170-190 .
31. Levin, R., A. Braiman, and Z. Priel. 1997. Protein kinase C induced calcium influx and sustained enhancement of ciliary beating by extracellular ATP. Cell Calcium 21: 103-113 [Medline].
32. Korngreen, A., and Z. Priel. 1994. Simultaneous measurement of ciliary beating and intracellular calcium. Biophys. J. 67: 377-380 [Medline].
33.
Korngreen, A., and
Z. Priel.
1996.
Purinergic stimulation of rabbit ciliated
airway epithelia: control by multiple calcium sources.
J. Physiol.
497:
53-66
34. Bonini, N. M., T. C. Evans, L. A. P. Miglietta, and D. L. Nelson. 1991. The regulation of ciliary motility in Paramecium by Ca2+ and cyclic nucleotides. Adv. Second Messenger Phosphoprotein Res. 23: 227-272 [Medline].
35. Habermacher, G., and W. S. Sale. 1995. Regulation of dynein-driven microtubule sliding by an axonemal kinase and phosphatase in Chlamydomonas flagella. Cell Motil. Cytoskeleton 32: 106-109 [Medline].
This article has been cited by other articles:
![]() |
S. L. Stout, T. A. Wyatt, J. J. Adams, and J. H. Sisson Nitric Oxide-dependent Cilia Regulatory Enzyme Localization in Bovine Bronchial Epithelial Cells J. Histochem. Cytochem., May 1, 2007; 55(5): 433 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Elliott, J. H. Sisson, and T. A. Wyatt Effects of Cigarette Smoke and Alcohol on Ciliated Tracheal Epithelium and Inflammatory Cell Recruitment Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 452 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Bove, U. V. Wesley, A.-K. Greul, M. Hristova, W. R. Dostmann, and A. van der Vliet Nitric Oxide Promotes Airway Epithelial Wound Repair through Enhanced Activation of MMP-9 Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 138 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lapointe, M. Roy, I. St-Pierre, S. Kimmins, D. Gauvreau, L. A. MacLaren, and J.-F. Bilodeau Hormonal and Spatial Regulation of Nitric Oxide Synthases (NOS) (Neuronal NOS, Inducible NOS, and Endothelial NOS) in the Oviducts Endocrinology, December 1, 2006; 147(12): 5600 - 5610. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zaman, S. Carraro, J. Doherty, E. M. Henderson, E. Lendermon, L. Liu, G. Verghese, M. Zigler, M. Ross, E. Park, et al. S-Nitrosylating Agents: A Novel Class of Compounds That Increase Cystic Fibrosis Transmembrane Conductance Regulator Expression and Maturation in Epithelial Cells Mol. Pharmacol., October 1, 2006; 70(4): 1435 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gaston, D. Singel, A. Doctor, and J. S. Stamler S-Nitrosothiol Signaling in Respiratory Biology Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1186 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Wyatt, M. A. Forget, J. M. Adams, and J. H. Sisson Both cAMP and cGMP are required for maximal ciliary beat stimulation in a cell-free model of bovine ciliary axonemes Am J Physiol Lung Cell Mol Physiol, March 1, 2005; 288(3): L546 - L551. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Konig, J. Dedio, S. Oess, T. Papadakis, A. Fischer, W. Muller-Esterl, and W. Kummer NOSIP and Its Interacting Protein, eNOS, in the Rat Trachea and Lung J. Histochem. Cytochem., February 1, 2005; 53(2): 155 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang and M. J Sanderson The role of cGMP in the regulation of rabbit airway ciliary beat frequency J. Physiol., September 15, 2003; 551(3): 765 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Wyatt, M. A. Forget, and J. H. Sisson Ethanol Stimulates Ciliary Beating by Dual Cyclic Nucleotide Kinase Activation in Bovine Bronchial Epithelial Cells Am. J. Pathol., September 1, 2003; 163(3): 1157 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Doran, C. H. Tran, C. Eskicioglu, T. Stachniak, K.-C. Ahn, and J. I. Goldberg Constitutive and permissive roles of nitric oxide activity in embryonic ciliary cells Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R348 - R355. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhan, D. Li, and R. A. Johns Expression of Endothelial Nitric Oxide Synthase in Ciliated Epithelia of Rats J. Histochem. Cytochem., January 1, 2003; 51(1): 81 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Cole, A. Mashkournia, S. C. Parries, and J. I. Goldberg Regulation of early embryonic behavior by nitric oxide in the pond snail Helisoma trivolvis J. Exp. Biol., October 15, 2002; 205(20): 3143 - 3152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Snyder, M. E. McPherson, J. F. Hunt, M. Johnson, J. S. Stamler, and B. Gaston Acute Effects of Aerosolized S-Nitrosoglutathione in Cystic Fibrosis Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 922 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Suzuki, H. Kojima, Y. Urano, K. Kikuchi, Y. Hirata, and T. Nagano Orthogonality of Calcium Concentration and Ability of 4,5-Diaminofluorescein to Detect NO J. Biol. Chem., January 4, 2002; 277(1): 47 - 49. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |